
zzso and type 2 diabetes have reached epidemic proportions zzso These zzso disorders, particularly zzso are zzso by increased zzso sympathetic nervous system zzso activity but an impaired sympathetic response to certain zzso such as zzso Although targeting the zzso may seem an attractive avenue for the pharmacological prevention and treatment of obesity and related zzso disorders, it remains unknown whether changes in zzso tone are primary and contribute to the development of these zzso conditions or whether they develop secondary to the obese zzso This question can be answered by the study of zzso individuals prior to the development of obesity and type 2 zzso Using this model, it has been shown that early insulin resistance is associated with increased zzso activity in zzso zzso It has been suggested that in zzso states, zzso is the initiating factor that increases sympathetic neural zzso Over time, zzso zzso and/or reduced sensitivity are likely to zzso resulting in reduced sympathetic zzso In the zzso state, this will lead to impaired zzso zzso and zzso fat zzso promoting the zzso of body zzso More recent evidence demonstrates that zzso zzso zzso zzso zzso Y, an zzso hormone, and its zzso zzso in visceral zzso zzso the fat depot most strongly linked to insulin resistance and type 2 zzso There is evidence that zzso zzso specifically contributes to the development of abdominal obesity via this pathway, which could represent a novel target for the prevention and treatment of abdominal obesity and related zzso zzso 

